The Food and Drug Administration approved a breakthrough pancreatic cancer treatment, found to double survival to thirteen months compared to people who just got chemotherapy. It’s called Rasonque, and it’s approved for patients with advanced pancreatic cancer. NBC News’ Anne Thompson reports.